Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations.

TORONTO – Health Canada has granted a medical license to Toronto-based pharmaceuticals company Hls Therapeutics Inc. for a device that simplifies blood monitoring for patients suffering from treatment-resistant schizophrenia (TRS).

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.